Financials

  • Market Capitalization 69.55 M
  • Employee 20
  • Founded 2008
  • CEO N/A
  • Website www.ibioinc.com
  • Headquarter Delaware, United States
  • FIGI BBG000D5F2L9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.44
ratio cours/chiffre d'affaires
20.03

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4075
CSBR
Champions Oncology, Inc. - Common Stock
5.36 USD+1.71%-12.13%-10.22%-19.03%74.47 M USD
4096
GANX
Gain Therapeutics, Inc. - Common Stock
1.68 USD-4.55%-6.15%-15.58%+13.51%71.66 M USD
4121
XBIT
XBiotech Inc. - Common Stock
2.23 USD-0.45%-1.76%-3.46%-25.17%67.99 M USD
4124
SPRO
Spero Therapeutics, Inc. - Common Stock
1.17 USD-2.50%-4.10%-47.53%-45.58%67.74 M USD

Nouvelles